Lv1
50 积分 2023-05-09 加入
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study
9天前
已完结
Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults
9天前
已完结
Assessing the clinical progress of the bispecific nanobody sonelokimab
9天前
已完结
Bispecific T-cell engagers (BiTE): a review of tarlatamab in small cell lung cancer
23天前
已完结
Nanobodies: Natural Single-Domain Antibodies
1个月前
已完结
Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis
3个月前
已完结
Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy
5个月前
已完结
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
5个月前
已完结
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology
5个月前
已完结
皖公网安备34019202002308
